Abstract
The purpose of this study is to update our institution's experience with ipsilateral radiation therapy (RT) for squamous cell carcinoma of the tonsillar area. Outcome study of 76 patients treated between 1984 and 2012 with ipsilateral RT for squamous cell carcinoma of the tonsil. Patients had either cT1 (n=41, 54%) or cT2 (n=35, 46%) primaries and cN0 (n=27, 36%), cN1 (n=15, 20%), cN2a (n=8, 11%), or cN2b (n=26, 34%) nodal disease. Of these, 32 (42%) patients underwent a planned neck dissection and 21 (28%) patients received concomitant chemotherapy. Median follow-up for all patients was 7.1years (range 0.1-27.2) and 7.8years (range 2.1-27.2years) for living patients. The 2- and 5-year control and survival rates were as follows: local control, 98.6 and 96.9%; local-regional control 95.8 and 92.6%; cause-specific survival 95.9 and 93.1%; and overall survival, 92.1 and 83.8%. One patient failed in the contralateral, non-radiated neck 3years after primary treatment. Univariate analysis revealed that overall survival was significantly influenced by whether the patient had a primary tumor in the anterior tonsillar pillar versus the tonsillar fossa with the latter performing better. The incidence of severe late complications was 16%. Ipsilateral RT for patients with squamous cell carcinoma of the anterior tonsillar pillar or tonsillar fossa with no base of tongue or soft palate extension is an efficacious treatment that provides excellent control rates with a relatively low incidence of late complications.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call